强效,选择性和口服生物可用的CK1α分子降解剂的结构-活性关系
Gisele Nishiguchi1, Elizabeth A Caine2, Kevin McGowan1
1Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105, United States.
研究人员开发了针对CK1α的新型分子降解剂,CK1α是癌症中的关键蛋白质. 这些新化合物表现出强大的降解活性和抗癌作用,具有有希望的口服生物可用性,用于潜在的治疗用途.
科学领域:
- 药用化学 医学化学
- 分子药理学分子药理学
- 在瘤学瘤学.
背景情况:
- 原始的分子降解剂结合cereblon (CRBN) 来降解IKZF1,IKZF3和CK1α等新基质.
- 了解和调节新基质特异性对于开发向癌症疗法至关重要.
- 此前,SJ3149已被确定为在癌症细胞系中活跃的选择性CK1α降解剂.
研究的目的:
- 描述导致SJ3149和相关的强大的CK1α降解剂的药物化学努力.
- 研究这些新型CK1α降解剂的机制和疗效.
- 评估它们作为抗癌疗法的潜力.
主要方法:
- 药用化学优化和新型分子降解剂的合成.
- 关于CK1α降解和三元复合体形成的动态概况.
- 对抗生殖增殖效应的评估,体外ADME和体内药理动力学.
主要成果:
- 发现SJ3149和其他强大的,选择性的CK1α降解剂.
- 确定了CK1α降解的详细动力学参数.
- 证明了抗增殖作用和良好的体内药理动力学,具有口服生物可用性.
结论:
- 成功的药物化学努力产生了强大的CK1α选择性分子降解剂.
- 这些化合物表现出有前途的抗癌活性和类似药物的特性.
- 进一步开发这些CK1α降解剂有可能用于癌症治疗.
更多相关视频
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
07:22Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
Published on: January 12, 2024
相关概念视频
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Enzymes
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
